Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Guidelines for Sinusitis Agreed to by Allergists, Otolaryngologist - Head and Neck Surgeons

07.12.2004


Rhinosinusitis, the inflammation of the mucous membrane of the nose and sinuses, has increased in both prevalence and incidence. Health officials believe that this disorder, also known as sinusitis, causes significant physical symptoms, negatively affects quality of life, and can substantially impair daily functions. It is now estimated that rhinosinusitis affects approximately 31 million Americans each year.



Recognizing a need for evidence-based rhinosinusitis guidelines, five national societies,The American Academy of Allergy, Asthma and Immunology (AAAAI); The American Academy of Otolaryngic Allergy; The American Academy of Otolaryngology -- Head and Neck Surgery (AAO-HNS); The American College of Allergy, Asthma and Immunology; and the American Rhinologic Society convened a panel of 30 physicians from a wide range of disciplines to develop definitions of rhinosinusitis for clinical research, and suggest clinical trial designs for studies that would allow for more appropriate use of pharmacologic, immunologic, and surgical interventions.

For the clinician, existing definitions of the disease fail to describe all manifestations of rhinosinusitis. This is due, in part, to the numerous causes of rhinosinusitis, which can be viral, bacterial, fungal, allergic, and for some patients, of unknown origin. Rhinosinusitis can be acute or chronic (the latter defined by the Sinus and Allergy Health Partnership as “a group of disorders characterized by inflammation of the mucosa of the nose and paranasal sinuses of at least 12 weeks’ duration." (Otolaryngology Head and Neck Surgery, September 2003)). Other classes i.e., subacute, recurrent acute, acute exacerbation of chronic, community acquired bacterial, and nosocomial, have been used in medical literature.


“We believed that the lack of a consensus definition for chronic rhinosinusitis hampered efforts to conduct research studies or to attempt studies of medical treatment,” agreed Eli O. Meltzer, MD, a member of the AAAAI’s Sinusitis Committee and James Hadley, MD, Past President of both the AAOA and ARS.

Their findings are provided in a supplement, “Rhinosinusitis: Establishing Definitions for Clinical Research and Patient Care,” published concurrently in the December 2004 editions of the Journal of Allergy & Clinical Immunology (JACI) http://www.mosby.com/jaci/ and Otolaryngology – Head and Neck Surgery (OTO-HNS) http://www.mosby.com/oto/. The corresponding author is Eli O. Meltzer, MD, Co-Director, Allergy and Asthma Medical Group and Research Center, San Diego, CA.

Findings: After two days of meeting, this panel was able to reach consensus (more than 80 percent of committee members) on definitions and clinical research strategies for acute (bacterial) rhinosinusitis, chronic rhinosinusitis without polyps, chronic rhinosinusitis with polyps, and allergic fungal rhinosinusitis. Other conclusions reached were:

* No one etiologic factor fully explains or adequately accounts for the pathologic manifestations and clinical differences found in rhinosinusitis. The inflammatory component of these disorders manifests as a mixed mononuclear inflammatory cell infiltrate with neutrophils predominating in acute disease and eosinophils predominating in most chronic disease.

* Chronic rhinosinusitis has a significant inflammatory component that may be caused simultaneously or independently by various factors. These include but are not restricted to the possible roles of: persistent infection as a factor in chronic rhinosinusitis including biofilms and “osteitis” (inflammation of the bone); allergy and other disorders of immunity; intrinsic factors of the upper airway; super antigens from Staphylococcus aureus in chronic rhinosinusitis with nasal polyps; colonizing fungi that induce and sustain eosinophilic inflammation; and metabolic perturbations such as aspirin sensitivity.

The panel agreed on consensus definitions for rhinosinusitis as applied to (1) acute presumed bacterial rhinosinusitis; (2) chronic rhinosinusitis without polyps; (3) chronic rhinosinusitis with polyps; and (4) classic allergic fungal rhinosinusitis. Additionally, initial proposals were made for clinical trial designs, including an outline of suggested subjective and objective assessments applicable to these studies.

Conclusions: The definitions and guidelines outlined in “Rhinosinusitis: Establishing Definitions for Clinical Research and Patient Care,” will be invaluable to physicians who diagnose and treat sinusitis and the clinicians and researchers responsible for developing and implementing appropriate clinical studies.

The work of this important consensus panel will serve as a catalyst for further research of this debilitating disorder. But the participants in this effort agree that 1) promoting more research on both acute and chronic rhinosinusitis is essential; 2) a better understanding of the cause of these diseases is needed; 3) study designs for the evaluation of potential therapeutic modalities for rhinosinusitis, as well as appropriate outcome studies must be carefully considered.

The AAAAI is the largest professional medical specialty organization in the United States representing allergists, asthma specialists, clinical immunologists, allied health professionals and others with a special interest in the research and treatment of allergic disease. Allergy/immunology specialists are pediatric or internal medicine physicians who have elected an additional two years of training to become specialized in the treatment of asthma, allergy and immunologic disease. Established in 1943, the AAAAI has nearly 6,000 members in the United States, Canada and 60 other countries. The AAAAI serves as an advocate to the public by providing educational information through its Web site at http://www.aaaai.org.

The American Academy of Otolaryngology – Head and Neck Surgery http://www.entnet.org, one of the oldest medical associations in the nation, represents more than 10,000 physicians and allied health professionals who specialize in the diagnosis and treatment of disorders of the ears, nose, throat, and related structures of the head and neck. The Academy serves its members by facilitating the advancement of the science and art of medicine related to otolaryngology and by representing the specialty in governmental and socioeconomic issues. The organization’s mission is: “Working for the Best Ear, Nose, and Throat Care.”

| newswise
Further information:
http://www.aaaai.org
http://www.entnet.org

More articles from Health and Medicine:

nachricht Study suggests possible new target for treating and preventing Alzheimer's
02.12.2016 | Oregon Health & Science University

nachricht The first analysis of Ewing's sarcoma methyloma opens doors to new treatments
01.12.2016 | IDIBELL-Bellvitge Biomedical Research Institute

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

Im Focus: Molecules change shape when wet

Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water

In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...

Im Focus: Fraunhofer ISE Develops Highly Compact, High Frequency DC/DC Converter for Aviation

The efficiency of power electronic systems is not solely dependent on electrical efficiency but also on weight, for example, in mobile systems. When the weight of relevant components and devices in airplanes, for instance, is reduced, fuel savings can be achieved and correspondingly greenhouse gas emissions decreased. New materials and components based on gallium nitride (GaN) can help to reduce weight and increase the efficiency. With these new materials, power electronic switches can be operated at higher switching frequency, resulting in higher power density and lower material costs.

Researchers at the Fraunhofer Institute for Solar Energy Systems ISE together with partners have investigated how these materials can be used to make power...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

UTSA study describes new minimally invasive device to treat cancer and other illnesses

02.12.2016 | Medical Engineering

Plasma-zapping process could yield trans fat-free soybean oil product

02.12.2016 | Agricultural and Forestry Science

What do Netflix, Google and planetary systems have in common?

02.12.2016 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>